Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
Tóm tắt
Từ khóa
Tài liệu tham khảo
Merli, 2003, Incidence and natural history of small esophageal varices in cirrhotic patients, J Hepatol, 38, 266, 10.1016/S0168-8278(02)00420-8
Carbonell, 2004, Improved survival after variceal bleeding in patients with cirrhosis over the past two decades, HEPATOLOGY, 40, 652, 10.1002/hep.20339
McCormick, 2001, Improving prognosis following a first variceal haemorrhage over four decades, Gut, 49, 682, 10.1136/gut.49.5.682
Cheng, 2003, Meta analysis of propranolol effects on gastrointestinal hemorrhage in cirrhotic patients, World J Gastroenterol, 9, 1836, 10.3748/wjg.v9.i8.1836
Hayes, 1990, Meta-analysis of value of propranolol in prevention of variceal hemorrhage, Lancet, 336, 153, 10.1016/0140-6736(90)91668-Z
Gluud, 2007, Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials, Am J Gastroenterol, 102, 2842, 10.1111/j.1572-0241.2007.01564.x
Tripathi, 2007, Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis, Eur J Gastroenterol Hepatol, 19, 835, 10.1097/MEG.0b013e3282748f07
Bartsch, 1982, Pharmakologie und klinische pharmakologie des neuen vasodila tierenden beta-rezeptoren blockers BM 14190, Therapiewoche, 32, 5714
Albillos, 1994, Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension, HEPATOLOGY, 20, 611
Koshy, 1992, Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension, J Gastroenterol Hepatol, 7, 449, 10.1111/j.1440-1746.1992.tb01018.x
Vorobioff, 1987, Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients, HEPATOLOGY, 7, 648, 10.1002/hep.1840070406
Tripathi, 2002, Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension, Aliment Pharmacol Ther, 16, 373, 10.1046/j.1365-2036.2002.01190.x
Stanley, 1999, Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis, J Hepatol, 30, 479, 10.1016/S0168-8278(99)80108-1
Sekiyama, 1997, Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension, Arzneimittelforschung, 47, 353
Lin, 2004, Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis, Am J Gastroenterol, 99, 1953, 10.1111/j.1572-0241.2004.40179.x
Forrest, 1996, Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis, J Hepatol, 25, 909, 10.1016/S0168-8278(96)80296-0
De, 2002, Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics, J Gastroenterol Hepatol, 17, 183, 10.1046/j.1440-1746.2002.02674.x
Bruha, 2006, Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes, Scand J Gastroenterol, 41, 1454, 10.1080/00365520600780403
Banares, 1999, Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis, HEPATOLOGY, 30, 79, 10.1002/hep.510300124
Banares, 2002, Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis, HEPATOLOGY, 36, 1367, 10.1053/jhep.2002.36947
Ferguson, 2005, Techniques in Gastrointestinal Endoscopy, 2
de Franchis, 2000, Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension, J Hepatol, 33, 846, 10.1016/S0168-8278(00)80320-7
Sarin, 1999, Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding, N Engl J Med, 340, 988, 10.1056/NEJM199904013401302
Jutabha, 2005, Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices, Gastroenterology, 128, 870, 10.1053/j.gastro.2005.01.047
Psilopoulos, 2005, Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial, Eur J Gastroenterol Hepatol, 17, 1111, 10.1097/00042737-200510000-00016
Neugebauer, 1990, Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound, Eur J Clin Pharmacol, 38, S108, 10.1007/BF01409476
Neugebauer, 1992, Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction, J Cardiovasc Pharmacol, 19, S142, 10.1097/00005344-199219001-00028
Lui, 2002, Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate, Gastroenterology, 123, 735, 10.1053/gast.2002.35385
Lay, 2006, Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis, J Gastroenterol Hepatol, 21, 413, 10.1111/j.1440-1746.2005.04071.x
Lo, 2004, Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis, Gastrointest Endosc, 59, 333, 10.1016/S0016-5107(03)02819-0
Schepke, 2004, Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis, HEPATOLOGY, 40, 65, 10.1002/hep.20284
Thuluvath, 2005, A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates, Dig Dis Sci, 50, 407, 10.1007/s10620-005-1619-8
Norberto, 2007, A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation, Liver Transpl, 13, 1272, 10.1002/lt.21083
Yoshida, 2005, A randomized control trial of bi-monthly versus bi-weekly endoscopic variceal ligation of esophageal varices, Am J Gastroenterol, 100, 2005, 10.1111/j.1572-0241.2005.41864.x
Harewood, 2006, Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding, J Gastroenterol Hepatol, 21, 237, 10.1111/j.1440-1746.2006.04169.x
Garcia-Tsao, 2007, Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis, HEPATOLOGY, 46, 922, 10.1002/hep.21907
Triantos, 2006, Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe?, HEPATOLOGY, 43, 196, 10.1002/hep.20881
Shaheen, 2005, Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial, HEPATOLOGY, 41, 588, 10.1002/hep.20593